(0.29%) 5 114.65 points
(0.37%) 38 380 points
(0.36%) 15 986 points
(-1.63%) $82.48
(5.20%) $2.02
(0.26%) $2 353.40
(0.25%) $27.61
(3.94%) $958.40
(-0.21%) $0.933
(-0.35%) $10.99
(-0.53%) $0.796
(1.68%) $93.42
2 days till quarter result
(bmo 2024-05-01)
Expected move: +/- 14.14%
Live Chart Being Loaded With Signals
NeuroMetrix, Inc., a healthcare company, engages in designing, building, and marketing medical devices that stimulate and analyze nerve response for diagnostic and therapeutic purposes in the United States, Europe, Japan, China, the Middle East, and Mexico...
Stats | |
---|---|
आज की मात्रा | 7 667.00 |
औसत मात्रा | 50 182.00 |
बाजार मूल्य | 8.96M |
EPS | $0 ( 2024-02-22 ) |
अगली कमाई की तारीख | ( $0 ) 2024-05-01 |
Last Dividend | $1 728.00 ( 2007-03-28 ) |
Next Dividend | $0 ( N/A ) |
P/E | -0.720 |
ATR14 | $0.0400 (0.89%) |
Date | Person | Action | Amount | type |
---|---|---|---|---|
2024-04-18 | Horowitz Joshua | Buy | 16 438 | Common Stock |
2024-04-18 | Horowitz Joshua | Buy | 0 | Common Stock |
2024-04-18 | Horowitz Joshua | Sell | 0 | Common Stock |
2024-04-01 | Higgins Thomas T | Buy | 469 | Common Stock |
2024-04-01 | Higgins Thomas T | Sell | 74 | Common Stock |
INSIDER POWER |
---|
54.21 |
Last 97 transactions |
Buy: 971 558 | Sell: 254 579 |
NeuroMetrix Inc सहसंबंध
10 सबसे अधिक सकारात्मक सहसंबंध |
---|
10 सबसे अधिक नकारात्मक सहसंबंध |
---|
क्या आप जानते हैं?
कोरलेशन एक सांख्यिकीय माप है जो दो चरों के बीच संबंध का वर्णन करता है। यह -1 से 1 तक का होता है, जहाँ -1 एक पूर्ण नकारात्मक कोरलेशन को दर्शाता है (जैसे ही एक चर बढ़ता है, दूसरा कम होता है), 1 एक पूर्ण सकारात्मक कोरलेशन को दर्शाता है (जैसे ही एक चर बढ़ता है, दूसरा भी बढ़ता है) और 0 कोई कोरलेशन नहीं होता है (चरों के बीच कोई संबंध नहीं है)।
कोरलेशन किसी भी दो चरों के बीच संबंध का विश्लेषण करने के लिए इस्तेमाल किया जा सकता है, न कि केवल स्टॉक में। यह वित्तीय, अर्थशास्त्र, मनोविज्ञान और अन्य क्षेत्रों में आमतौर पर उपयोग किया जाता है।
NeuroMetrix Inc वित्तीय
Annual | 2023 |
राजस्व: | $5.90M |
सकल लाभ: | $3.95M (66.89 %) |
EPS: | $-6.27 |
FY | 2023 |
राजस्व: | $5.90M |
सकल लाभ: | $3.95M (66.89 %) |
EPS: | $-6.27 |
FY | 2022 |
राजस्व: | $8.26M |
सकल लाभ: | $5.75M (69.65 %) |
EPS: | $-4.90 |
FY | 2021 |
राजस्व: | $8.25M |
सकल लाभ: | $5.92M (71.75 %) |
EPS: | $-0.342 |
Financial Reports:
No articles found.
NeuroMetrix Inc Dividends
(Q3/22) | (Q4/22) | (Q1/23) | (Q2/23) | (Q3/23) | (Q4/23) | (Q1/24) | (Q2/24) | (Q3/24) | (Q4/24) |
$0 (N/A) |
$0 (N/A) |
$0 (N/A) |
$0 (N/A) |
$0 (N/A) |
$0 (N/A) |
$0 (N/A) |
$0 (N/A) |
$0 (N/A) |
$0 (N/A) |
First Dividend | $1 728.00 | 2007-03-28 |
Last Dividend | $1 728.00 | 2007-03-28 |
Next Dividend | $0 | N/A |
Payout Date | 2007-04-13 | |
Next Payout Date | N/A | |
# dividends | 1 | -- |
Total Paid Out | $1 728.00 | -- |
Avg. Dividend % Per Year | 0.00% | -- |
Score | 0.01 | -- |
Div. Sustainability Score | 0 | |
Div.Growth Potential Score | 0 | |
Div. Directional Score | 0 | -- |
Year | Amount | Yield |
---|---|---|
2007 | $1.000 | 0.00% |
2008 | $0 | 0.00% |
2009 | $0 | 0.00% |
2010 | $0 | 0.00% |
2011 | $0 | 0.00% |
2012 | $0 | 0.00% |
2013 | $0 | 0.00% |
2014 | $0 | 0.00% |
2015 | $0 | 0.00% |
2016 | $0 | 0.00% |
2017 | $0 | 0.00% |
2018 | $0 | 0.00% |
2019 | $0 | 0.00% |
2020 | $0 | 0.00% |
2021 | $0 | 0.00% |
2022 | $0 | 0.00% |
2023 | $0 | 0.00% |
2024 | $0 | 0.00% |
The company does not currently pay dividends. Given its current dividend status and a low Dividend Growth Potential Score (DGPS), there's minimal likelihood of dividends being initiated soon. Considering all factors, the near-term dividend outlook for the company remains unpromising.
Symbol | Title | Last dividend | Frequency | Years Dividend | Yearly Dividend | Score |
---|---|---|---|---|---|---|
OXLC | Dividend Royal | 2023-12-14 | Monthly | 14 | 10.00% | 8.50 |
OXSQ | Dividend Diamond | 2023-12-14 | Monthly | 21 | 9.10% | 8.50 |
PSEC | Dividend Royal | 2023-12-26 | Monthly | 21 | 7.04% | 8.50 |
SLVO | Dividend Royal | 2023-11-20 | Monthly | 12 | 10.77% | 8.50 |
QYLD | Dividend Royal | 2023-11-20 | Monthly | 11 | 7.50% | 8.50 |
GAIN | Dividend Royal | 2023-12-04 | Monthly | 20 | 8.19% | 8.50 |
GLDI | Dividend Royal | 2023-11-20 | Monthly | 12 | 7.15% | 8.50 |
HRZN | Dividend King | 2023-12-18 | Monthly | 15 | 6.60% | 8.45 |
USOI | Dividend Royal | 2023-11-20 | Monthly | 8 | 16.70% | 8.28 |
PFLT | Dividend King | 2023-11-15 | Monthly | 14 | 6.50% | 8.27 |
Ratio | Actual Value | Weight | Normalized Value | Score | Range |
---|---|---|---|---|---|
netProfitMarginTTM | -1.083 | 1.500 | -10.00 | -10.00 | [0 - 0.5] |
returnOnAssetsTTM | -0.298 | 1.200 | -9.95 | -10.00 | [0 - 0.3] |
returnOnEquityTTM | -0.307 | 1.500 | -4.52 | -6.78 | [0.1 - 1] |
payoutRatioTTM | 0 | -1.000 | 0 | 0 | [0 - 1] |
currentRatioTTM | 16.81 | 0.800 | 10.00 | 8.00 | [1 - 3] |
quickRatioTTM | 14.92 | 0.800 | 10.00 | 8.00 | [0.8 - 2.5] |
cashRatioTTM | 1.396 | 1.500 | 3.36 | 5.03 | [0.2 - 2] |
debtRatioTTM | 0.0112 | -1.500 | 9.81 | -10.00 | [0 - 0.6] |
interestCoverageTTM | 52.63 | 1.000 | 10.00 | 10.00 | [3 - 30] |
operatingCashFlowPerShareTTM | -3.99 | 2.00 | -1.330 | -2.66 | [0 - 30] |
freeCashFlowPerShareTTM | -4.11 | 2.00 | -2.06 | -4.11 | [0 - 20] |
debtEquityRatioTTM | 0.0120 | -1.500 | 9.95 | -10.00 | [0 - 2.5] |
grossProfitMarginTTM | 0.669 | 1.000 | 2.19 | 2.19 | [0.2 - 0.8] |
operatingProfitMarginTTM | -1.212 | 1.000 | -10.00 | -10.00 | [0.1 - 0.6] |
cashFlowToDebtRatioTTM | -25.26 | 1.000 | -10.00 | -10.00 | [0.2 - 2] |
assetTurnoverTTM | 0.275 | 0.800 | -1.497 | -1.198 | [0.5 - 2] |
Total Score | -0.253 |
Ratio | Actual Value | Weight | Normalized Value | Score | Range |
---|---|---|---|---|---|
peRatioTTM | -1.059 | 1.000 | -0.208 | 0 | [1 - 100] |
returnOnEquityTTM | -0.307 | 2.50 | -2.90 | -6.78 | [0.1 - 1.5] |
freeCashFlowPerShareTTM | -4.11 | 2.00 | -1.370 | -4.11 | [0 - 30] |
dividendYielPercentageTTM | 0 | 1.500 | 0 | 0 | [0 - 0.4] |
operatingCashFlowPerShareTTM | -3.99 | 2.00 | -1.330 | -2.66 | [0 - 30] |
payoutRatioTTM | 0 | 1.500 | 0 | 0 | [0 - 1] |
pegRatioTTM | -0.0361 | 1.500 | -3.57 | 0 | [0.5 - 2] |
operatingCashFlowSalesRatioTTM | -1.031 | 1.000 | -10.00 | 0 | [0.1 - 0.5] |
Total Score | -2.82 |
NeuroMetrix Inc
NeuroMetrix, Inc., a healthcare company, engages in designing, building, and marketing medical devices that stimulate and analyze nerve response for diagnostic and therapeutic purposes in the United States, Europe, Japan, China, the Middle East, and Mexico. Its primary marketed products include DPNCheck, a nerve conduction test that is used to evaluate peripheral neuropathies, such as diabetic peripheral neuropathy; Quell, a wearable device for symptomatic relief and management of chronic pain; and ADVANCE system, a platform for the performance of nerve conduction studies. The company offers its products to managed care organizations, endocrinologists, podiatrists, and primary care physicians; occupational health, primary care, internal medicine, orthopedic, and hand surgeons; and pain medicine physicians, neurologists, physical medicine and rehabilitation physicians, and neurosurgeons. NeuroMetrix, Inc. was incorporated in 1996 and is headquartered in Woburn, Massachusetts.
के बारे में लाइव सिग्नल्स
इस पृष्ठ पर प्रस्तुत लाइव सिग्नल्स NA को कब खरीदना या बेचना है, इसका निर्धारण करने में मदद करते हैं। सिग्नल्स में 1-मिनट की देरी हो सकती है; सभी बाजार सिग्नल्स की तरह, त्रुटि या गलतियों की संभावना होती है।
लाइव ट्रेडिंग सिग्नल्स स्थायी नहीं हैं, और getagraph.com इन सिग्नल्स पर किए गए किसी भी कार्रवाई के लिए जिम्मेदारी नहीं रखते हैं, जैसा कि उपयोग की शर्तें में वर्णित है। सिग्नल्स एक व्यापक श्रृंखला के तकनीकी विश्लेषण संकेतकों पर आधारित हैं